2020
DOI: 10.1016/j.jviromet.2019.113772
|View full text |Cite
|
Sign up to set email alerts
|

Rapid manipulation of the porcine epidemic diarrhea virus genome by CRISPR/Cas9 technology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
30
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 22 publications
(31 citation statements)
references
References 32 publications
1
30
0
Order By: Relevance
“…In contrast, we used the BAC‐based system combined with homologous recombination technology to construct a full‐length cDNA infectious clone for PDCoV. This system shows several comparative advantages over its counterparts (Jengarn et al., 2015; Li et al., 2017; Peng et al., 2020). Firstly, this vector system is capable of efficiently accommodating large foreign genes and thus is suitable for the construction of infectious cDNA clone for the viruses with large genomes.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, we used the BAC‐based system combined with homologous recombination technology to construct a full‐length cDNA infectious clone for PDCoV. This system shows several comparative advantages over its counterparts (Jengarn et al., 2015; Li et al., 2017; Peng et al., 2020). Firstly, this vector system is capable of efficiently accommodating large foreign genes and thus is suitable for the construction of infectious cDNA clone for the viruses with large genomes.…”
Section: Discussionmentioning
confidence: 99%
“…Briefly, several vital elements including CMV promoter (initiating viral RNA synthesis), partial N-terminal end of PDCoV genome (nt 1–375, containing a restriction enzyme site of AvrII), C-terminal end of PDCoV genome (nt 23365–25421, containing restriction enzyme site of BamHI), a 27-residue poly (A) tail, hepatitis deltavirus (HDV) ribozyme self-cleavage site and bovine growth hormone (BGH) termination sequences (efficiently stopping the transcription) [ 41 ], were cloned into pBeloBAC11 vector through the restriction sites ApaLI and HindIII ( Figure 1 A), producing an intermediate plasmid (pBAC-M-PDCoV). PDCoV-infected LLC-PK1 cells were subjected to the total RNA extraction using TRIzol reagent (Invitrogen, Carlsbad, CA, USA).…”
Section: Methodsmentioning
confidence: 99%
“…To establish a rapid and sensitive anti-PDCoV drug screening platform, a Nluc gene with many preponderant features, including small size, stability, and higher bioluminescence activity was designed to replace the NS6 gene due to its nonessential requirement for normal viral replication [ 38 ]. Recombinant PDCoV expressing Nluc was constructed on the basis of CRISPR/Cas9 technology, as described previously [ 41 ]. Briefly, two specific primers (sgPDCoV-ΔNS6a and sgPDCoV-ΔNS6b) targeting the upstream (523 bp) and downstream (578 bp) sequences of the NS6 gene were designed and synthesized.…”
Section: Methodsmentioning
confidence: 99%
“…In the current study, K289 in PEDV nsp13 was also verified as being important for ATPase and helicase activities. We attempted to generate recombinant PEDV with a K289A mutation in nsp13 via the infectious clone of PEDV strain AJ1102 ( Peng et al, 2020 ), the recombinant PEDV with a K289A mutation could not be successfully rescued, further demonstrating that K289 is essential for nsp13 helicase activity and is pivotal for viral survival.…”
Section: Discussionmentioning
confidence: 99%